Updates on eyelid cancers
In this review, we aim to provide an overview of the five most common malignant eyelid tumors with current treatment recommendations based on international guidelines. Particular attention is paid to the clinicopathological correlation and the update with regard to adequate treatment. Newer systemic...
Gespeichert in:
| Veröffentlicht in: | Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) Pa.), 2024-03, Vol.13 (2), p.100057, Article 100057 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 2 |
| container_start_page | 100057 |
| container_title | Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) |
| container_volume | 13 |
| creator | Schoelles, Kristina Joana Auw-Haedrich, Claudia |
| description | In this review, we aim to provide an overview of the five most common malignant eyelid tumors with current treatment recommendations based on international guidelines. Particular attention is paid to the clinicopathological correlation and the update with regard to adequate treatment. Newer systemic therapies enrich the existing treatment options, of which complete tumor excision remains the most important therapeutic measure. |
| doi_str_mv | 10.1016/j.apjo.2024.100057 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3039233462</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2162098924000525</els_id><sourcerecordid>3039233462</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-1e941d4295bf60dc6759dcb070dff3fed4445fed248fbdca4ac5f1ea16be5dd3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbKn9AXqQHr2kzn42AS9S_IKCl3peNruzkJA2cTcR-u_dkiqePM0wPO8L8xByQ2FJgar7emm6ul0yYCIdAOTqjEwZVSyDIi_O_-wTMo-xTggooMDySzLhuaKyADEl1x-dMz3GRbtf4AGbyi2s2VsM8YpceNNEnJ_mjGyfn7br12zz_vK2ftxklkvaZxQLQZ1ghSy9AmfVShbOlrAC5z336IQQMg0mcl86a4Sx0lM0VJUoneMzcjfWdqH9HDD2eldFi01j9tgOUXPgBeNcKJZQNqI2tDEG9LoL1c6Eg6agj1J0rY9S9FGKHqWk0O2pfyh36H4jPwoS8DACmJ78qjDoaCtMClwV0PbatdV__d_TDXF0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3039233462</pqid></control><display><type>article</type><title>Updates on eyelid cancers</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Schoelles, Kristina Joana ; Auw-Haedrich, Claudia</creator><creatorcontrib>Schoelles, Kristina Joana ; Auw-Haedrich, Claudia</creatorcontrib><description>In this review, we aim to provide an overview of the five most common malignant eyelid tumors with current treatment recommendations based on international guidelines. Particular attention is paid to the clinicopathological correlation and the update with regard to adequate treatment. Newer systemic therapies enrich the existing treatment options, of which complete tumor excision remains the most important therapeutic measure.</description><identifier>ISSN: 2162-0989</identifier><identifier>EISSN: 2162-0989</identifier><identifier>DOI: 10.1016/j.apjo.2024.100057</identifier><identifier>PMID: 38615904</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Eyelid cancer therapy ; Eyelid cancers ; Eyelid Neoplasms - pathology ; Eyelid Neoplasms - therapy ; Humans ; Ophthalmopathology</subject><ispartof>Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), 2024-03, Vol.13 (2), p.100057, Article 100057</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c351t-1e941d4295bf60dc6759dcb070dff3fed4445fed248fbdca4ac5f1ea16be5dd3</cites><orcidid>0000-0002-3408-341X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,862,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38615904$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schoelles, Kristina Joana</creatorcontrib><creatorcontrib>Auw-Haedrich, Claudia</creatorcontrib><title>Updates on eyelid cancers</title><title>Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)</title><addtitle>Asia Pac J Ophthalmol (Phila)</addtitle><description>In this review, we aim to provide an overview of the five most common malignant eyelid tumors with current treatment recommendations based on international guidelines. Particular attention is paid to the clinicopathological correlation and the update with regard to adequate treatment. Newer systemic therapies enrich the existing treatment options, of which complete tumor excision remains the most important therapeutic measure.</description><subject>Eyelid cancer therapy</subject><subject>Eyelid cancers</subject><subject>Eyelid Neoplasms - pathology</subject><subject>Eyelid Neoplasms - therapy</subject><subject>Humans</subject><subject>Ophthalmopathology</subject><issn>2162-0989</issn><issn>2162-0989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRbKn9AXqQHr2kzn42AS9S_IKCl3peNruzkJA2cTcR-u_dkiqePM0wPO8L8xByQ2FJgar7emm6ul0yYCIdAOTqjEwZVSyDIi_O_-wTMo-xTggooMDySzLhuaKyADEl1x-dMz3GRbtf4AGbyi2s2VsM8YpceNNEnJ_mjGyfn7br12zz_vK2ftxklkvaZxQLQZ1ghSy9AmfVShbOlrAC5z336IQQMg0mcl86a4Sx0lM0VJUoneMzcjfWdqH9HDD2eldFi01j9tgOUXPgBeNcKJZQNqI2tDEG9LoL1c6Eg6agj1J0rY9S9FGKHqWk0O2pfyh36H4jPwoS8DACmJ78qjDoaCtMClwV0PbatdV__d_TDXF0</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Schoelles, Kristina Joana</creator><creator>Auw-Haedrich, Claudia</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3408-341X</orcidid></search><sort><creationdate>202403</creationdate><title>Updates on eyelid cancers</title><author>Schoelles, Kristina Joana ; Auw-Haedrich, Claudia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-1e941d4295bf60dc6759dcb070dff3fed4445fed248fbdca4ac5f1ea16be5dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Eyelid cancer therapy</topic><topic>Eyelid cancers</topic><topic>Eyelid Neoplasms - pathology</topic><topic>Eyelid Neoplasms - therapy</topic><topic>Humans</topic><topic>Ophthalmopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schoelles, Kristina Joana</creatorcontrib><creatorcontrib>Auw-Haedrich, Claudia</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schoelles, Kristina Joana</au><au>Auw-Haedrich, Claudia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Updates on eyelid cancers</atitle><jtitle>Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)</jtitle><addtitle>Asia Pac J Ophthalmol (Phila)</addtitle><date>2024-03</date><risdate>2024</risdate><volume>13</volume><issue>2</issue><spage>100057</spage><pages>100057-</pages><artnum>100057</artnum><issn>2162-0989</issn><eissn>2162-0989</eissn><abstract>In this review, we aim to provide an overview of the five most common malignant eyelid tumors with current treatment recommendations based on international guidelines. Particular attention is paid to the clinicopathological correlation and the update with regard to adequate treatment. Newer systemic therapies enrich the existing treatment options, of which complete tumor excision remains the most important therapeutic measure.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38615904</pmid><doi>10.1016/j.apjo.2024.100057</doi><orcidid>https://orcid.org/0000-0002-3408-341X</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2162-0989 |
| ispartof | Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), 2024-03, Vol.13 (2), p.100057, Article 100057 |
| issn | 2162-0989 2162-0989 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3039233462 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Eyelid cancer therapy Eyelid cancers Eyelid Neoplasms - pathology Eyelid Neoplasms - therapy Humans Ophthalmopathology |
| title | Updates on eyelid cancers |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T00%3A37%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Updates%20on%20eyelid%20cancers&rft.jtitle=Asia-Pacific%20journal%20of%20ophthalmology%20(Philadelphia,%20Pa.)&rft.au=Schoelles,%20Kristina%20Joana&rft.date=2024-03&rft.volume=13&rft.issue=2&rft.spage=100057&rft.pages=100057-&rft.artnum=100057&rft.issn=2162-0989&rft.eissn=2162-0989&rft_id=info:doi/10.1016/j.apjo.2024.100057&rft_dat=%3Cproquest_cross%3E3039233462%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3039233462&rft_id=info:pmid/38615904&rft_els_id=S2162098924000525&rfr_iscdi=true |